Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125
G. Allen, A. Forouzannia, H. Bailey, and S. Howard Non-Hodgkin's lymphoma presenting as a pelvic mass with elevated CA-125 Gynecol. Oncol. 94 2004 811 813
HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma
D. Pham, T. Guthrie, and B. Ndubisi HIV-associated primary cervical non-Hodgkin's lymphoma and two other cases of primary pelvic non-Hodgkin's lymphoma Gynecol. Oncol. 90 2003 204 206
Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation
E.L. Stroh, C.B. Pelayo, J.D. Cox, L.M. Fuller, and F.F. Cabanillas Treatment of patients with lymphomas of the uterus or cervix with combination chemotherapy and radiation Cancer 75 1995 2392 2399
FDG PET in the follow-up management of newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy
W.C. Lavely, D. Delbeke, and J.P. Greer FDG PET in the follow-up management of newly diagnosed Hodgkin and non-Hodgkin lymphoma after first-line chemotherapy Oncol. Biol. Phys. 57 2003 307 315
Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: Correlation with tumor parameters and disease activity
M. Lazzarino, E. Orlandi, C. Klersy, C. Astori, E. Brusamolino, and A. Corso Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: correlation with tumor parameters and disease activity Cancer 82 1998 576 582